Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Boston Scientific Agrees To Pay $4.2Bn For UK Interventional Oncology Firm BTG

Nov 20 2018

• By Ashley Yeo

Businesswoman drawing The big fish eats the small fish on chalkboard — • Source: shutterstock.com

Related Content

Bringing The Clinician's Rationale Into The Heart Of Strategic Decision-Making At Boston Scientific

Sep 17 2018

A Chance To Own The Venous Space: BTG Acquires Novate

Oct 10 2018

Related Companies

Boston Scientific Corporation

BTG plc

Veran Medical Technologies

Boston Scientific Corporation

Additional Topics

M & A Business Strategies Commercial Cancer Medical Device

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window